SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001571049-15-002527
Filing Date
2015-03-31
Accepted
2015-03-31 17:10:18
Documents
12
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K t1500580-10k.htm 10-K 1312823
2 EXHIBIT 23.1 t1500580_ex23-1.htm EX-23.1 1802
3 EXHIBIT 31.1 t1500580_ex31-1.htm EX-31.1 10674
4 EXHIBIT 31.2 t1500580_ex31-2.htm EX-31.2 10284
5 EXHIBIT 32.1 t1500580_ex32-1.htm EX-32.1 3955
6 EXHIBIT 32.2 t1500580_ex32-2.htm EX-32.2 4026
  Complete submission text file 0001571049-15-002527.txt   7740307

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE cycc-20141231.xml EX-101.INS 937836
8 XBRL SCHEMA FILE cycc-20141231.xsd EX-101.SCH 62491
9 XBRL CALCULATION FILE cycc-20141231_cal.xml EX-101.CAL 66319
10 XBRL DEFINITION FILE cycc-20141231_def.xml EX-101.DEF 235360
11 XBRL LABEL FILE cycc-20141231_lab.xml EX-101.LAB 575097
12 XBRL PRESENTATION FILE cycc-20141231_pre.xml EX-101.PRE 408831
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-50626 | Film No.: 15740240
SIC: 2834 Pharmaceutical Preparations